Tick-derived Kunitz-type inhibitors as antihemostatic factors

Insect Biochemistry and Molecular Biology

Volumn 39, Issue 9, 2009, Pages 579-595

  Corral Rodríguez, María Ángeles ^a   Macedo Ribeiro, Sandra ^b   Barbosa Pereira, Pedro José ^b   Fuentes Prior, Pablo ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Coagulation factors; Exosites; Factor Xa; Hematophagous arthropods; Kunitz inhibitors; Structure; Thrombin; Tick derived inhibitors

Indexed keywords

ANTICOAGULANT AGENT; PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HUMAN; INSECT BITE; METABOLISM; MOLECULAR GENETICS; REVIEW; SEQUENCE ALIGNMENT; TICK;

AMINO ACID SEQUENCE; ANIMALS; ANTICOAGULANTS; HUMANS; INSECT BITES AND STINGS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; SEQUENCE ALIGNMENT; TICKS;

ARGASIDAE; ARTHROPODA; BOOPHILUS; IXODES SCAPULARIS; IXODIDA; IXODIDAE; ORNITHODOROS MOUBATA; RHIPICEPHALUS;

EID: 68749088605     PISSN: 09651748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ibmb.2009.07.003     Document Type: Review

References (108)

1. Antuch W., Güntert P., Billeter M., Hawthorne T., Grossenbacher H., and Wüthrich K. NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata. FEBS Lett. 352 (1994) 251-257
2. Arocha-Piñango C.L., Marchi R., Carvajal Z., and Guerrero B. Invertebrate compounds acting on the hemostatic mechanism. Blood Coagul. Fibrinol. 10 (1999) 43-68
3. Arocha-Piñango C.L., Marchi R., and Guerrero B. Inventory of exogenous hemostatic factors derived from arthropods. Thromb. Haemost. 81 (1999) 647-667
4. Ascenzi P., Coletta M., Amiconi G., de Cristofaro R., Bolognesi M., Guarneri M., and Menegatti E. Binding of the bovine basic pancreatic trypsin inhibitor (Kunitz) to human alpha-, beta- and gamma-thrombin; a kinetic and thermodynamic study. Biochim. Biophys. Acta 956 (1988) 156-161
5. Ascenzi P., Bocedi A., Bolognesi M., Spallarossa A., Coletta M., De Cristofaro R., and Menegatti E. The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein. Curr. Protein Pept. Sci. 4 (2003) 231-251
6. Beati L., and Keirans J.E. Analysis of the systematic relationships among ticks of the genera Rhipicephalus and Boophilus (Acari: ixodidae) based on mitochondrial 12S ribosomal DNA gene sequences and morphological characters. J. Parasitol. 87 (2001) 32-48
7. Betz A., Vlasuk G.P., Bergum P.W., and Krishnaswamy S. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa. Biochemistry 36 (1997) 181-191
8. Bode W., Mayr I., Baumann U., Huber R., Stone S.R., and Hofsteenge J. The refined 1.9 Å crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment. EMBO J. 8 (1989) 3467-3475
9. Bode W., Turk D., and Karshikov A. The refined 1.9-Å X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1 (1992) 426-471
10. Bode W., and Huber R. Structural basis of the endoproteinase-protein inhibitor interaction. Biochim. Biophys. Acta 1477 (2000) 241-252
11. Brandstetter H., Künhe A., Bode W., Huber R., von de Saal W., Wirthensohn K., and Engh R.A. X-ray structure of active site-inhibited clotting factor Xa: implications for drug design and substrate recognition. J. Biol. Chem. 271 (1996) 29988-29992
12. Broze Jr. G.J. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46 (1995) 103-112
13. Broze Jr. G.J., Girard T.J., and Novotny W.F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29 (1990) 7539-7546
14. Ceraul S.M., Dreher-Lesnick S.M., Mulenga A., Rahman M.S., and Azad A.F. Functional characterization and novel rickettsiostatic effects of a Kunitz-type serine protease inhibitor from the tick Dermacentor variabilis. Infect. Immun. 76 (2008) 5429-5435
15. Champagne D.E. Antihemostatic strategies of blood-feeding arthropods. Curr. Drug Targets - Cardiovasc. Hematol. Disord. 4 (2004) 375-396
16. Champagne D.E. Antihemostatic molecules from saliva of blood-feeding arthropods. Pathophysiol. Haemost. Thromb. 34 (2005) 221-227
17. Chang J.-Y. The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI. Biochemistry 35 (1996) 11702-11709
18. Chang J.-Y., Li L., and Bulychev A. The underlying mechanism for the diversity of disulfide folding pathways. J. Biol. Chem. 275 (2000) 8287-8289
19. Chang J.-Y., and Li L. Divergent folding pathways of two homologous proteins, BPTI and tick anticoagulant peptide: compartmentalization of folding intermediates and identification of kinetic traps. Arch. Biochem. Biophys. 437 (2005) 85-95
20. Chen L., Manithody C., Yang L., and Rezaie A.R. Zymogenic and enzymatic properties of the 70-80 loop mutants of factor X/Xa. Protein Sci. 13 (2004) 431-442
21. Chen H.-H., Vicente C.P., He L., Tollefsen D.M., and Wun T.-C. Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants. Blood 105 (2005) 3902-3909
22. Ciprandi A., de Oliveira S.K., Masuda A., Horn F., and Termignoni C. Boophilus microplus: its saliva contains microphilin, a small thrombin inhibitor. Exp. Parasitol. 114 (2006) 40-46
23. Dale G.L., Friese P., Batar P., Hamilton S.F., Reed G.L., Jackson K.W., Clemetson K.J., and Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415 (2002) 175-179
24. Davie E.W. A brief historical review of the waterfall/cascade of blood coagulation. J. Biol. Chem. 278 (2003) 50819-50832
25. Davie E.W., and Ratnoff O.D. Waterfall sequence for intrinsic blood clotting. Science 145 (1964) 1310-1312
26. Dunwiddie C.T., Neeper M.P., Nutt E.M., Waxman L., Smith D.E., Hofmann K.J., Lumma P.K., Garsky V.M., and Vlasuk G.P. Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites. Biochemistry 31 (1992) 12126-12131
27. Felsenstein J. PHYLIP - phylogeny inference package (version 3.2). Cladistics 5 (1989) 164-166
28. Fioravanti C., Burkholder D., Francis B., Siegl P.K.S., and Gibson R.E. Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. Thromb. Res. 71 (1993) 317-324
29. Francischetti I.M., Valenzuela J.G., Andersen J.F., Mather T.N., and Ribeiro J.M. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood 99 (2002) 3602-3612
30. Francischetti I.M.B., Mather T.N., and Ribeiro J.M.C. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis. Thromb. Haemost. 91 (2004) 886-898
31. Francischetti I.M.B., My Pham V., Mans B.J., Andersen J.F., Mather T.N., Lane R.S., and Ribeiro J.M.C. The transcriptome of the salivary glands of the female western black-legged tick Ixodes pacificus (Acari: ixodidae). Insect Biochem. Mol. Biol. 35 (2005) 1142-1161
32. Francischetti I.M.B., Mans B.J., Meng Z., Gudderra N., Veenstra T.D., Pham V.M., and Ribeiro J.M.C. An insight into the sialome of the soft tick, Ornithodorus parkeri. Insect Biochem. Mol. Biol. 38 (2008) 1-21
33. Gaspar A.R., Joubert A.M., Crause J.C., and Neitz A.W.H. Isolation and characterization of an anticoagulant from the salivary glands of the tick, Ornithodoros savignyi (Acari: argasidae). Exp. Appl. Acarol. 20 (1996) 583-598
34. Girard T.J., Warren L.A., Novotny W.F., Likert K.M., Brown S.G., Miletich J.P., and Broze Jr. G.J. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature 338 (1989) 518-520
35. Grütter M.G., Priestle J.P., Rahuel J., Grossenbacher H., Bode W., Hofsteenge J., and Stone S.R. Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J. 9 (1990) 2361-2365
36. Grzesiak A., Helland R., Smalas A.O., Krowarsch D., Dadlez M., and Otlewski J. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases. J. Mol. Biol. 301 (2000) 205-217
37. Guinto E.R., Ye J., Le Bonniec B.F., and Esmon C.T. Glu192 → Gln substitution in thrombin yields an enzyme that is effectively inhibited by bovine pancreatic trypsin inhibitor and tissue factor pathway inhibitor. J. Biol. Chem. 269 (1994) 18395-18400
38. Hagemeyer C.E., Tomic I., Jaminet P., Weirich U., Bassler N., Schwarz M., Runge M.S., Bode C., and Peter K. Fibrin-targeted direct factor Xa inhibition: construction and characterization of a recombinant factor Xa inhibitor composed of an anti-fibrin single-chain antibody and tick anticoagulant peptide. Thromb. Haemost. 92 (2004) 47-53
39. Horn F., dos Santos P.C., and Termignoni C. Boophilus microplus anticoagulant protein: an antithrombin inhibitor isolated from the cattle tick saliva. Arch. Biochem. Biophys. 384 (2000) 68-73
40. Iwanaga S., Okada M., Isawa H., Morita A., Yuda M., and Chinzei Y. Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis. Eur. J. Biochem. 270 (2003) 1926-1934
41. Jordan S.P., Waxman L., Smith D.E., and Vlasuk G.P. Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor X.alpha. Biochemistry 29 (1990) 11095-11100
42. Jordan S.P., Mao S.S., Lewis S.D., and Shafer J.A. Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide. Biochemistry 31 (1992) 5374-5380
43. Joubert A.M., Louw A.I., Joubert F., and Neitz A.W.H. Cloning, nucleotide sequence and expression of the gene encoding factor Xa inhibitor from the salivary glands of the tick, Ornithodoros savignyi. Exp. Appl. Acarol. 22 (1998) 603-619
44. Kamata K., Kawamoto H., Honma T., Iwama T., and Kim S.-H. Structural basis for chemical inhibition of human blood coagulation factor Xa. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6630-6635
45. Karczewski J., Endris R., and Connolly T.M. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata. J. Biol. Chem. 269 (1994) 6702-6708
46. Kato N., Iwanaga S., Okayama T., Isawa H., Yuda M., and Chinzei Y. Identification and characterization of the plasma kallikrein-kinin system inhibitor, haemaphysalin, from hard tick, Haemaphysalis longicornis. Thromb. Haemost. 93 (2005) 359-367
47. Kato N., Okayama T., Isawa H., Yuda M., Chinzei Y., and Iwanaga S. Contribution of the N-terminal and C-terminal domains of haemaphysalin to inhibition of activation of plasma kallikrein-kinin system. J. Biochem. 138 (2005) 225-235
48. Klingler J., and Friedrich T. Site-specific interaction of thrombin and inhibitors observed by fluorescence correlation spectroscopy. Biophys. J. 73 (1997) 2195-2200
49. Krishnaswamy S., Vlasuk G.P., and Bergum P.W. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. Biochemistry 33 (1994) 7897-7907
50. Lai R., Takeuchi H., Jonczy J., Rees H.H., and Turner P.C. A thrombin inhibitor from the ixodid tick, Amblyomma hebraeum. Gene 342 (2004) 243-249
51. Le Bonniec B.F., and Esmon C.T. Glu-192 → Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7371-7375
52. Le Bonniec B.F., MacGillivray R.T., and Esmon C.T. Thrombin Glu-39 restricts the P′3 specificity to nonacidic residues. J. Biol. Chem. 266 (1991) 13796-13803
53. Le Bonniec B.F., Guinto E.R., MacGillivray R.T., Stone S.R., and Esmon C.T. The role of thrombin's Tyr-Pro-Pro-Trp motif in the interaction with fibrinogen, thrombomodulin, protein C, antithrombin III, and the Kunitz inhibitors. J. Biol. Chem. 268 (1993) 19055-19061
54. Le Bonniec B.F., Myles T., Johnson T., Knight C.G., Tapparelli C., and Stone S.R. Characterization of the P2′ and P3′ specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis. Biochemistry 35 (1996) 7114-7122
55. Ledizet M., Harrison L.M., Koski R.A., and Cappello M. Discovery and pre-clinical development of antithrombotics from hematophagous invertebrates. Curr. Med. Chem. - Cardiovasc. Hematol. Agents 3 (2005) 1-10
56. Liao M., Zhou J., Gong H., Boldbaatar D., Shirafuji R., Battur B., Nishikawa Y., and Fujisaki K. Hemalin, a thrombin inhibitor isolated from a midgut cDNA library from the hard tick Haemaphysalis longicornis. J. Insect Physiol. 55 (2009) 165-174
57. Lim-Wilby M.S., Hallenga K., Maeyer M.d., Lasters I., Vlasuk G.P., and Brunck T.K. NMR structure determination of tick anticoagulant peptide (TAP). Protein Sci. 4 (1995) 178-186
58. Macedo-Ribeiro S., Almeida C., Calisto B.M., Friedrich T., Mentele R., Stürzebecher J., Fuentes-Prior P., and Pereira P. Isolation, cloning and structural characterisation of boophilin, a multifunctional Kunitz-type proteinase inhibitor from the cattle tick. PLoS ONE 3 (2008) e1624
59. Macfarlane R.G. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202 (1964) 498-499
60. Manithody C., Yang L., and Rezaie A.R. Role of basic residues of the autolysis loop in the catalytic function of factor Xa. Biochemistry 41 (2002) 6780-6788
61. Mans B., Louw A., and Neitz A. Disaggregation of aggregated platelets by savignygrin, a αIIbβ3 antagonist from Ornithodoros savignyi. Exp. Appl. Acarol. 27 (2002) 231-239
62. Mans B.J., Louw A.I., and Neitz A.W. Amino acid sequence and structure modeling of savignin, a thrombin inhibitor from the tick, Ornithodoros savignyi. Insect Biochem. Mol. Biol. 32 (2002) 821-828
63. Mans B.J., Louw A.I., and Neitz A.W.H. Evolution of hematophagy in ticks: common origins for blood coagulation and platelet aggregation inhibitors from soft ticks of the genus Ornithodoros. Mol. Biol. Evol. 19 (2002) 1695-1705
64. Mans B.J., Louw A.I., and Neitz A.W.H. Savignygrin, a platelet aggregation inhibitor from the soft tick Ornithodoros savignyi, presents the RGD integrin recognition motif on the Kunitz-BPTI fold. J. Biol. Chem. 277 (2002) 21371-21378
65. Mans B.J., Andersen J.F., Francischetti I.M.B., Valenzuela J.G., Schwan T.G., Pham V.M., Garfield M.K., Hammer C.H., and Ribeiro J.M.C. Comparative sialomics between hard and soft ticks: implications for the evolution of blood-feeding behavior. Insect Biochem. Mol. Biol. 38 (2008) 42-58
66. Mans B.J., Andersen J.F., Schwan T.G., and Ribeiro J.M.C. Characterization of anti-hemostatic factors in the argasid, Argas monolakensis: implications for the evolution of blood-feeding in the soft tick family. Insect Biochem. Mol. Biol. 38 (2008) 22-41
67. Mans B.J., and Neitz A.W. The mechanism of [alpha]IIb[beta]3 antagonism by savignygrin and its implications for the evolution of anti-hemostatic strategies in soft ticks. Insect Biochem. Mol. Biol. 34 (2004) 573-584
68. Mans B.J., and Neitz A.W.H. Adaptation of ticks to a blood-feeding environment: evolution from a functional perspective. Insect Biochem. Mol. Biol. 34 (2004) 1-17
69. Mao S.-S., Huang J., Welebob C., Neeper M.P., Garsky V.M., and Shafer J.A. Identification and characterization of variants of tick anticoagulant peptide with increased inhibitory potency toward human factor Xa. Biochemistry 34 (1995) 5098-5103
70. Marque P.-E., Spuntarelli R., Juliano L., Aiach M., and Le Bonniec B.F. The role of Glu192 in the allosteric control of the S2′ and S3′ subsites of thrombin. J. Biol. Chem. 275 (2000) 809-816
71. Monteiro R.Q., Rezaie A.R., Ribeiro J.M., and Francischetti I.M. Ixolaris: a factor Xa heparin-binding exosite inhibitor. Biochem. J. 387 (2005) 871-877
72. Monteiro R.Q., Rezaie A.R., Bae J.-S., Calvo E., Andersen J.F., and Francischetti I.M. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite. Protein Sci. 17 (2008) 146-153
73. Nakajima C., Imamura S., Konnai S., Yamada S., Nishikado H., Ohashi K., and Onuma M. A novel gene encoding a thrombin inhibitory protein in a cDNA library from Haemaphysalis longicornis salivary gland. J. Vet. Med. Sci. 68 (2006) 447-452
74. Nazareth R.A., Tomaz L.S., Ortiz-Costa S., Atella G.C., Ribeiro J.M.C., Francischetti I.M.B., and Monteiro R.Q. Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade. Thromb. Haemost. 96 (2006) 7-13
75. Nienaber J., Gaspar A.R., and Neitz A.W. Savignin, a potent thrombin inhibitor isolated from the salivary glands of the tick Ornithodoros savignyi (Acari: argasidae). Exp. Parasitol. 93 (1999) 82-91
76. Padmanabhan K., Padmanabhan K.P., Tulinsky A., Park C.H., Bode W., Huber R., Blankenship D.T., Cardin A.D., and Kisiel W. Structure of human des(1-45) factor Xa at 2.2 A resolution. J. Mol. Biol. 232 (1993) 947-966
77. Paesen G.C., Siebold C., Harlos K., Peacey M.F., Nuttall P.A., and Stuart D.I. A tick protein with a modified Kunitz fold inhibits human tryptase. J. Mol. Biol. 368 (2007) 1172-1186
78. Pereira P.J.B., Bergner A., Macedo-Ribeiro S., Huber R., Matschiner G., Fritz H., Sommerhoff C.P., and Bode W. Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature 392 (1998) 306-311
79. Perona J.J., and Craik C.S. Evolutionary divergence of substrate specificity within the chymotrypsin-like serine protease fold. J. Biol. Chem. 272 (1997) 29987-29990
80. Pintigny D., and Dachary-Prigent J. Aprotinin can inhibit the proteolytic activity of thrombin. A fluorescence and an enzymatic study. Eur. J. Biochem. 207 (1992) 89-95
81. Ponte P., DeWhitt P.G., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331 (1988) 525-527
82. Ragosta M., Gimple L.W., Gertz S.D., Dunwiddie C.T., Vlasuk G.P., Haber H.L., Powers E.R., Roberts W.C., and Sarembock I.J. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation 89 (1994) 1262-1271
83. Rawlings N.D., Tolle D.P., and Barrett A.J. Evolutionary families of peptidase inhibitors. Biochem. J. 378 (2004) 705-716
84. Rezaie A.R. Kinetics of factor Xa inhibition by recombinant tick anticoagulant peptide: both active site and exosite interactions are required for a slow- and tight-binding inhibition mechanism. Biochemistry 43 (2004) 3368-3375
85. Ribeiro J.M. Blood-feeding arthropods: live syringes or invertebrate pharmacologists?. Infect. Agents Dis. 4 (1995) 143-152
86. Ribeiro J.M.C., and Francischetti I.M.B. Role of arthropod saliva in blood feeding: sialome and post-sialome perspectives. Annu. Rev. Entomol. 48 (2003) 73-88
87. Ricci C., Pinto A., Berger M., and Termignoni C. A thrombin inhibitor from the gut of Boophilus microplus ticks. Exp. Appl. Acarol. 42 (2007) 291-300
88. Rice P., Longden I., and Bleasby A. EMBOSS: the European molecular biology open software suite. Trends Genet. 16 (2000) 276-277
89. Richardson J.L., Kroger B., Hoeffken W., Sadler J.E., Pereira P., Huber R., Bode W., and Fuentes-Prior P. Crystal structure of the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. EMBO J. 19 (2000) 5650-5660
90. Rydel T.J., Ravichandran K.G., Tulinsky A., Bode W., Huber R., Roitsch C., and Fenton II J.W. The structure of a complex of recombinant hirudin and human alpha-thrombin. Science 249 (1990) 277-280
91. Rydel T.J., Tulinsky A., Bode W., and Huber R. Refined structure of the hirudin-thrombin complex. J. Mol. Biol. 221 (1991) 583-601
92. Sardana M., Sardana V., Rodkey J., Wood T., Ng A., Vlasuk G.P., and Waxman L. Determination of disulfide bond pairs and stability in recombinant tick anticoagulant peptide. J. Biol. Chem. 266 (1991) 13560-13563
93. Schaffer L.W., Davidson J.T., Vlasuk G.P., and Siegl P.K. Antithrombotic efficacy of recombinant tick anticoagulant peptide. A potent inhibitor of coagulation factor Xa in a primate model of arterial thrombosis. Circulation 84 (1991) 1741-1748
94. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
95. Schwartz R.S., Holder D.J., Holmes Jr. D.R., Veinot J.P., Camrud A.R., Jorgenson M.A., and Johnson Jr. R.G. Neointimal thickening after severe coronary artery injury is limited by short-term administration of a factor Xa inhibitor: results in a porcine model. Circulation 93 (1996) 1542-1548
96. Sitko G.R., Ramjit D.R., Stabilito I.I., Lehman D., Lynch J.J., and Vlasuk G.P. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis. Circulation 85 (1992) 805-815
97. Stark K.R., and James A.A. Anticoagulants in vector arthropods. Parasitol. Today 12 (1996) 430
98. Stoll P., Bassler N., Hagemeyer C.E., Eisenhardt S.U., Chen Y.C., Schmidt R., Schwarz M., Ahrens I., Katagiri Y., Pannen B., et al. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 1206-1212
99. Stubbs M.T., Huber R., and Bode W. Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin. FEBS Lett. 375 (1995) 103-107
100. Theunissen H.J., Dijkema R., Grootenhuis P.D., Swinkels J.C., de Poorter T.L., Carati P., and Visser A. Dissociation of heparin-dependent thrombin and factor Xa inhibitory activities of antithrombin-III by mutations in the reactive site. J. Biol. Chem. 268 (1993) 9035-9040
101. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22 (1994) 4673-4680
102. Urata J., Shojo H., and Kaneko Y. Inhibition mechanisms of hematophagous invertebrate compounds acting on the host blood coagulation and platelet aggregation pathways. Biochimie 85 (2003) 493-500
103. van de Locht A., Stubbs M.T., Bode W., Friedrich T., Bollschweiler C., Hoffken W., and Huber R. The ornithodorin-thrombin crystal structure, a key to the TAP enigma?. EMBO J. 15 (1996) 6011-6017
104. van de Locht A., Bode W., Huber R., Le Bonniec B.F., Stone S.R., Esmon C.T., and Stubbs M.T. The thrombin E192Q-BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin. EMBO J. 16 (1997) 2977-2984
105. van Vlijmen H.W.T., Gupta A., Narasimhan L.S., and Singh J. A novel database of disulfide patterns and its application to the discovery of distantly related homologs. J. Mol. Biol. 335 (2004) 1083-1092
106. Waxman L., Smith D.E., Arcuri K.E., and Vlasuk G.P. Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa. Science 248 (1990) 593-596
107. Wei A., Alexander R.S., Duke J., Ross H., Rosenfeld S.A., and Chang C.-H. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa. J. Mol. Biol. 283 (1998) 147-154
108. Wikel S.K., and Bergman D. Tick-host immunology: significant advances and challenging opportunities. Parasitol. Today 13 (1997) 383-389